RNAZ · Transcode Therapeutics, Inc. · Fails to Deliver
$1.70
+0.00 (+0.00%)
At close · Oct 19
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Due to the Company's recurring and expected continuing losses from operations, the Company has concluded there is substantial doubt concerning its ability to continue as a going concern for one year after the issuance of these consolidated financial statements without additional capital becoming available.”View the 10-Q filed Aug 14, 2026
Market Cap
$28.78M
Shares
16.93M
Volume · Oct 19
29.32K
Avg daily vol (3M)
53.32K
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-29 | 463 | $1.71 | $792 |
| 2026-09-25 | 614 | $1.65 | $1,013 |
| 2026-09-24 | 11,172 | $1.68 | $18,769 |
| 2026-09-21 | 2,074 | $1.65 | $3,422 |
| 2026-09-16 | 895 | $1.60 | $1,432 |
| 2026-09-11 | 59 | $1.69 | $100 |
| 2026-09-08 | 112 | $2.06 | $231 |
| 2026-09-04 | 196 | $2.16 | $423 |
| 2026-09-01 | 18,108 | $2.10 | $38,027 |
| 2026-08-26 | 1,380 | $2.53 | $3,491 |
| 2026-08-25 | 2,777 | $2.70 | $7,498 |
| 2026-08-24 | 392 | $2.87 | $1,125 |
| 2026-08-20 | 22,384 | $3.21 | $71,853 |
| 2026-08-19 | 207 | $3.24 | $671 |
| 2026-08-18 | 29 | $3.16 | $92 |
| 2026-08-13 | 925 | $3.37 | $3,117 |
| 2026-08-07 | 140 | $4.12 | $577 |
| 2026-08-04 | 100 | $4.22 | $422 |
Showing 1–18 of 18 settlements